LoneStar Heart wins CE Mark approval in EU for hydrogel implant | Regulatory news for the week of October 6, 2014

Here's a look at some of the top regulatory stories for medical device companies this week: LoneStar Heart wins CE Mark for hydrogel heart implant; FDA launches cybersecurity initiative; Direct Flow Medical wins CE Mark for enhanced heart valve delivery device; FDA releases August 2014 PMAs; FDA doubtful on new Watchman data from Boston Scientific

LoneStar Heart wins CE Mark for hydrogel heart implant

October 1, 2014 by Alex Soule

Boston Scientific, Direct Flow Medical Inc., Food & Drug Administration (FDA), LoneStar Heart

News Well, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/10K5ymQ